You have 9 free searches left this month | for more free features.

Cisplatin

Showing 1 - 25 of 4,414

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Shanghai (ABX, cisplatin, Gemcitabine, Cisplatin)

Completed
  • Breast Cancer
  • ABX, cisplatin
  • Gemcitabine, Cisplatin
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 20, 2022

Nasopharyngeal Cancer Trial in Singapore (cisplatin and gemcitabine, induction chemo cisplatin, gemcitabine, bevacizumab and

Not yet recruiting
  • Nasopharyngeal Cancer
  • cisplatin and gemcitabine
  • induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
  • Singapore, Singapore
    National University Hospital
Mar 22, 2022

Chemo;Advanced Gastric Cancer;Cisplatin;Disulfiram Trial in Hangzhou (disulfiram and cisplatin, cisplatin)

Not yet recruiting
  • Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram
  • disulfiram and cisplatin
  • cisplatin
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 26, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Strasbourg (Split Cisplatin, Cisplatin, Radiotherapy)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Split Cisplatin
  • +2 more
  • Strasbourg, France
    Centre Paul Strauss
Mar 10, 2022

Pentoxifylline, Cisplatin, Nephrotoxixcity Trial (Pentoxifylline 400 mg SR tablets, cisplatin with standard hydration with

Not yet recruiting
  • Pentoxifylline, Cisplatin, Nephrotoxixcity
  • Pentoxifylline 400 mg SR tablets
  • cisplatin with standard hydration with normal saline
  • (no location specified)
Nov 30, 2022

Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Jun 8, 2022

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

Cisplatin Adverse Reaction Trial in Tanta (cisplatin with hydration magnesium)

Enrolling by invitation
  • Cisplatin Adverse Reaction
  • cisplatin with hydration magnesium
  • Tanta, Gharbiya, Egypt
    Mohamed Saad younis
Oct 25, 2022

METASTATIC CERVICAL CANCER Trial (QL1706, Placebo)

Not yet recruiting
  • METASTATIC CERVICAL CANCER
  • (no location specified)
Jun 30, 2022

Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Camrelizumab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 3, 2022

Nasopharyngeal Carcinoma Trial in Wuhan (raltitrexed-cisplatin, Intensity-modulated radiotherapy (IMRT))

Completed
  • Nasopharyngeal Carcinoma
  • Wuhan, Hubei, China
    Hubei Cancer hospital
Feb 4, 2022

Mesothelioma Trial in Houston (Pemetrexed, Cisplatin)

Terminated
  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Mar 15, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Cisplatin)

Recruiting
  • Hepatocellular Carcinoma
  • Cisplatin
  • Hong Kong, Hong Kong
    Department of Imaging and Interventional Radiology, Prince of Wa
Mar 10, 2022

ERCC1 and OCT2 on Occurrence and Severity of Cisplatin-induced

Not yet recruiting
  • Cisplatin Adverse Reaction
  • ERCC1
  • OCT2
  • Cairo, Egypt
    Faculty of medicine, Ain Shams University
Feb 9, 2022

Advanced Malignant Solid Tumors Trial in Changchun (Cisplatin micelle injection (HA132))

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Cisplatin micelle injection (HA132)
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Jul 28, 2022

Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)

Completed
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 8, 2022

Advanced Gastric Carcinoma, HER2-positive Gastric Cancer Trial in ZhengZhou (RC48+AK105+cisplatin)

Not yet recruiting
  • Advanced Gastric Carcinoma
  • HER2-positive Gastric Cancer
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 29, 2022

Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)

Active, not recruiting
  • Bile Duct Cancer
  • Intrahepatic Cholangiocarcinoma
  • Melphalan/HDS
  • Cisplatin and Gemcitabine
  • Durham, North Carolina
  • +2 more
Mar 23, 2022

Combining Genomics and Imageomics to Predict Sensitivity of

Not yet recruiting
  • Sensitivity
  • Neoadjuvant pemetrexed and cisplatin chemotherapy
  • (no location specified)
Jan 5, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 10, 2022

Cervical Cancer, Neoadjuvant Chemo Trial in Shantou (gemcitabine and cisplatin)

Recruiting
  • Cervical Cancer
  • Neoadjuvant Chemotherapy
  • gemcitabine and cisplatin
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Jan 18, 2022

Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine

Active, not recruiting
  • Local Advanced High Risk Nasopharyngeal Carcinoma
  • IMRT combine with cisplatin concurrent chemotherapy
  • IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Mar 13, 2022

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cisplatin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))

Recruiting
  • Pediatric Germ Cell Tumor
  • TIP treatment (paclitaxel/ifosfamide/cisplatin)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 8, 2022